Global OTC Anti-Infective Products Market Insights and Forecast to 2028

Publisher Name :
Date: 12-Jan-2022
No. of pages: 110
Inquire Before Buying

OTC Anti-Infective Products market is segmented by Type and by Sales Channel. Players, stakeholders, and other participants in the global OTC Anti-Infective Products market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Sales Channel for the period 2017-2028.

Segment by Type

- Antifungal

- Antibacterial

- Antiviral

- Antiseptics

- Others

Segment by Sales Channel

- Hospital Pharmacies

- Retail Pharmacies

- Online Pharmacies

By Company

- Bayer

- GSK

- Teva

- Johnson & Johnson

- NOVARTIS

- MYLAN

- Sun Pharma

- CR SANJIU

- Cipla

- Lingrui

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - China Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

Global OTC Anti-Infective Products Market Insights and Forecast to 2028

Table of Contents
1 Study Coverage
1.1 OTC Anti-Infective Products Product Introduction
1.2 Market by Type
1.2.1 Global OTC Anti-Infective Products Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Antifungal
1.2.3 Antibacterial
1.2.4 Antiviral
1.2.5 Antiseptics
1.2.6 Others
1.3 Market by Sales Channel
1.3.1 Global OTC Anti-Infective Products Market Size Growth Rate by Sales Channel, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global OTC Anti-Infective Products Sales Estimates and Forecasts 2017-2028
2.2 Global OTC Anti-Infective Products Revenue Estimates and Forecasts 2017-2028
2.3 Global OTC Anti-Infective Products Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global OTC Anti-Infective Products Sales by Region
2.4.1 Global OTC Anti-Infective Products Sales by Region (2017-2022)
2.4.2 Global Sales OTC Anti-Infective Products by Region (2023-2028)
2.5 Global OTC Anti-Infective Products Revenue by Region
2.5.1 Global OTC Anti-Infective Products Revenue by Region (2017-2022)
2.5.2 Global OTC Anti-Infective Products Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global OTC Anti-Infective Products Sales by Manufacturers
3.1.1 Global Top OTC Anti-Infective Products Manufacturers by Sales (2017-2022)
3.1.2 Global OTC Anti-Infective Products Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of OTC Anti-Infective Products in 2021
3.2 Global OTC Anti-Infective Products Revenue by Manufacturers
3.2.1 Global OTC Anti-Infective Products Revenue by Manufacturers (2017-2022)
3.2.2 Global OTC Anti-Infective Products Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by OTC Anti-Infective Products Revenue in 2021
3.3 Global OTC Anti-Infective Products Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global OTC Anti-Infective Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global OTC Anti-Infective Products Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global OTC Anti-Infective Products Sales by Type
4.1.1 Global OTC Anti-Infective Products Historical Sales by Type (2017-2022)
4.1.2 Global OTC Anti-Infective Products Forecasted Sales by Type (2023-2028)
4.1.3 Global OTC Anti-Infective Products Sales Market Share by Type (2017-2028)
4.2 Global OTC Anti-Infective Products Revenue by Type
4.2.1 Global OTC Anti-Infective Products Historical Revenue by Type (2017-2022)
4.2.2 Global OTC Anti-Infective Products Forecasted Revenue by Type (2023-2028)
4.2.3 Global OTC Anti-Infective Products Revenue Market Share by Type (2017-2028)
4.3 Global OTC Anti-Infective Products Price by Type
4.3.1 Global OTC Anti-Infective Products Price by Type (2017-2022)
4.3.2 Global OTC Anti-Infective Products Price Forecast by Type (2023-2028)
5 Market Size by Sales Channel
5.1 Global OTC Anti-Infective Products Sales by Sales Channel
5.1.1 Global OTC Anti-Infective Products Historical Sales by Sales Channel (2017-2022)
5.1.2 Global OTC Anti-Infective Products Forecasted Sales by Sales Channel (2023-2028)
5.1.3 Global OTC Anti-Infective Products Sales Market Share by Sales Channel (2017-2028)
5.2 Global OTC Anti-Infective Products Revenue by Sales Channel
5.2.1 Global OTC Anti-Infective Products Historical Revenue by Sales Channel (2017-2022)
5.2.2 Global OTC Anti-Infective Products Forecasted Revenue by Sales Channel (2023-2028)
5.2.3 Global OTC Anti-Infective Products Revenue Market Share by Sales Channel (2017-2028)
5.3 Global OTC Anti-Infective Products Price by Sales Channel
5.3.1 Global OTC Anti-Infective Products Price by Sales Channel (2017-2022)
5.3.2 Global OTC Anti-Infective Products Price Forecast by Sales Channel (2023-2028)
6 North America
6.1 North America OTC Anti-Infective Products Market Size by Type
6.1.1 North America OTC Anti-Infective Products Sales by Type (2017-2028)
6.1.2 North America OTC Anti-Infective Products Revenue by Type (2017-2028)
6.2 North America OTC Anti-Infective Products Market Size by Sales Channel
6.2.1 North America OTC Anti-Infective Products Sales by Sales Channel (2017-2028)
6.2.2 North America OTC Anti-Infective Products Revenue by Sales Channel (2017-2028)
6.3 North America OTC Anti-Infective Products Market Size by Country
6.3.1 North America OTC Anti-Infective Products Sales by Country (2017-2028)
6.3.2 North America OTC Anti-Infective Products Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe OTC Anti-Infective Products Market Size by Type
7.1.1 Europe OTC Anti-Infective Products Sales by Type (2017-2028)
7.1.2 Europe OTC Anti-Infective Products Revenue by Type (2017-2028)
7.2 Europe OTC Anti-Infective Products Market Size by Sales Channel
7.2.1 Europe OTC Anti-Infective Products Sales by Sales Channel (2017-2028)
7.2.2 Europe OTC Anti-Infective Products Revenue by Sales Channel (2017-2028)
7.3 Europe OTC Anti-Infective Products Market Size by Country
7.3.1 Europe OTC Anti-Infective Products Sales by Country (2017-2028)
7.3.2 Europe OTC Anti-Infective Products Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific OTC Anti-Infective Products Market Size by Type
8.1.1 Asia Pacific OTC Anti-Infective Products Sales by Type (2017-2028)
8.1.2 Asia Pacific OTC Anti-Infective Products Revenue by Type (2017-2028)
8.2 Asia Pacific OTC Anti-Infective Products Market Size by Sales Channel
8.2.1 Asia Pacific OTC Anti-Infective Products Sales by Sales Channel (2017-2028)
8.2.2 Asia Pacific OTC Anti-Infective Products Revenue by Sales Channel (2017-2028)
8.3 Asia Pacific OTC Anti-Infective Products Market Size by Region
8.3.1 Asia Pacific OTC Anti-Infective Products Sales by Region (2017-2028)
8.3.2 Asia Pacific OTC Anti-Infective Products Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America OTC Anti-Infective Products Market Size by Type
9.1.1 Latin America OTC Anti-Infective Products Sales by Type (2017-2028)
9.1.2 Latin America OTC Anti-Infective Products Revenue by Type (2017-2028)
9.2 Latin America OTC Anti-Infective Products Market Size by Sales Channel
9.2.1 Latin America OTC Anti-Infective Products Sales by Sales Channel (2017-2028)
9.2.2 Latin America OTC Anti-Infective Products Revenue by Sales Channel (2017-2028)
9.3 Latin America OTC Anti-Infective Products Market Size by Country
9.3.1 Latin America OTC Anti-Infective Products Sales by Country (2017-2028)
9.3.2 Latin America OTC Anti-Infective Products Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa OTC Anti-Infective Products Market Size by Type
10.1.1 Middle East and Africa OTC Anti-Infective Products Sales by Type (2017-2028)
10.1.2 Middle East and Africa OTC Anti-Infective Products Revenue by Type (2017-2028)
10.2 Middle East and Africa OTC Anti-Infective Products Market Size by Sales Channel
10.2.1 Middle East and Africa OTC Anti-Infective Products Sales by Sales Channel (2017-2028)
10.2.2 Middle East and Africa OTC Anti-Infective Products Revenue by Sales Channel (2017-2028)
10.3 Middle East and Africa OTC Anti-Infective Products Market Size by Country
10.3.1 Middle East and Africa OTC Anti-Infective Products Sales by Country (2017-2028)
10.3.2 Middle East and Africa OTC Anti-Infective Products Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Bayer
11.1.1 Bayer Corporation Information
11.1.2 Bayer Overview
11.1.3 Bayer OTC Anti-Infective Products Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Bayer OTC Anti-Infective Products Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bayer Recent Developments
11.2 GSK
11.2.1 GSK Corporation Information
11.2.2 GSK Overview
11.2.3 GSK OTC Anti-Infective Products Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 GSK OTC Anti-Infective Products Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 GSK Recent Developments
11.3 Teva
11.3.1 Teva Corporation Information
11.3.2 Teva Overview
11.3.3 Teva OTC Anti-Infective Products Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Teva OTC Anti-Infective Products Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Teva Recent Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Corporation Information
11.4.2 Johnson & Johnson Overview
11.4.3 Johnson & Johnson OTC Anti-Infective Products Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Johnson & Johnson OTC Anti-Infective Products Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Johnson & Johnson Recent Developments
11.5 NOVARTIS
11.5.1 NOVARTIS Corporation Information
11.5.2 NOVARTIS Overview
11.5.3 NOVARTIS OTC Anti-Infective Products Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 NOVARTIS OTC Anti-Infective Products Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 NOVARTIS Recent Developments
11.6 MYLAN
11.6.1 MYLAN Corporation Information
11.6.2 MYLAN Overview
11.6.3 MYLAN OTC Anti-Infective Products Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 MYLAN OTC Anti-Infective Products Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 MYLAN Recent Developments
11.7 Sun Pharma
11.7.1 Sun Pharma Corporation Information
11.7.2 Sun Pharma Overview
11.7.3 Sun Pharma OTC Anti-Infective Products Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Sun Pharma OTC Anti-Infective Products Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Sun Pharma Recent Developments
11.8 CR SANJIU
11.8.1 CR SANJIU Corporation Information
11.8.2 CR SANJIU Overview
11.8.3 CR SANJIU OTC Anti-Infective Products Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 CR SANJIU OTC Anti-Infective Products Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 CR SANJIU Recent Developments
11.9 Cipla
11.9.1 Cipla Corporation Information
11.9.2 Cipla Overview
11.9.3 Cipla OTC Anti-Infective Products Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Cipla OTC Anti-Infective Products Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Cipla Recent Developments
11.10 Lingrui
11.10.1 Lingrui Corporation Information
11.10.2 Lingrui Overview
11.10.3 Lingrui OTC Anti-Infective Products Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Lingrui OTC Anti-Infective Products Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Lingrui Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 OTC Anti-Infective Products Industry Chain Analysis
12.2 OTC Anti-Infective Products Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 OTC Anti-Infective Products Production Mode & Process
12.4 OTC Anti-Infective Products Sales and Marketing
12.4.1 OTC Anti-Infective Products Sales Channels
12.4.2 OTC Anti-Infective Products Distributors
12.5 OTC Anti-Infective Products Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 OTC Anti-Infective Products Industry Trends
13.2 OTC Anti-Infective Products Market Drivers
13.3 OTC Anti-Infective Products Market Challenges
13.4 OTC Anti-Infective Products Market Restraints
14 Key Findings in The Global OTC Anti-Infective Products Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global OTC Anti-Infective Products Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Antifungal
Table 3. Major Manufacturers of Antibacterial
Table 4. Major Manufacturers of Antiviral
Table 5. Major Manufacturers of Antiseptics
Table 6. Major Manufacturers of Others
Table 7. Global OTC Anti-Infective Products Market Size Growth Rate by Sales Channel, 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global OTC Anti-Infective Products Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global OTC Anti-Infective Products Sales by Region (2017-2022) & (M Units)
Table 10. Global OTC Anti-Infective Products Sales Market Share by Region (2017-2022)
Table 11. Global OTC Anti-Infective Products Sales by Region (2023-2028) & (M Units)
Table 12. Global OTC Anti-Infective Products Sales Market Share by Region (2023-2028)
Table 13. Global OTC Anti-Infective Products Revenue by Region (2017-2022) & (US$ Million)
Table 14. Global OTC Anti-Infective Products Revenue Market Share by Region (2017-2022)
Table 15. Global OTC Anti-Infective Products Revenue by Region (2023-2028) & (US$ Million)
Table 16. Global OTC Anti-Infective Products Revenue Market Share by Region (2023-2028)
Table 17. Global OTC Anti-Infective Products Sales by Manufacturers (2017-2022) & (M Units)
Table 18. Global OTC Anti-Infective Products Sales Share by Manufacturers (2017-2022)
Table 19. Global OTC Anti-Infective Products Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 20. Global OTC Anti-Infective Products Revenue Share by Manufacturers (2017-2022)
Table 21. OTC Anti-Infective Products Price by Manufacturers (2017-2022) &(US$/Unit)
Table 22. Global OTC Anti-Infective Products Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global OTC Anti-Infective Products by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Anti-Infective Products as of 2021)
Table 24. OTC Anti-Infective Products Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers OTC Anti-Infective Products Product Offered
Table 26. Date of Manufacturers Enter into OTC Anti-Infective Products Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global OTC Anti-Infective Products Sales by Type (2017-2022) & (M Units)
Table 29. Global OTC Anti-Infective Products Sales by Type (2023-2028) & (M Units)
Table 30. Global OTC Anti-Infective Products Sales Share by Type (2017-2022)
Table 31. Global OTC Anti-Infective Products Sales Share by Type (2023-2028)
Table 32. Global OTC Anti-Infective Products Revenue by Type (2017-2022) & (US$ Million)
Table 33. Global OTC Anti-Infective Products Revenue by Type (2023-2028) & (US$ Million)
Table 34. Global OTC Anti-Infective Products Revenue Share by Type (2017-2022)
Table 35. Global OTC Anti-Infective Products Revenue Share by Type (2023-2028)
Table 36. OTC Anti-Infective Products Price by Type (2017-2022) & (US$/Unit)
Table 37. Global OTC Anti-Infective Products Price Forecast by Type (2023-2028) & (US$/Unit)
Table 38. Global OTC Anti-Infective Products Sales by Sales Channel (2017-2022) & (M Units)
Table 39. Global OTC Anti-Infective Products Sales by Sales Channel (2023-2028) & (M Units)
Table 40. Global OTC Anti-Infective Products Sales Share by Sales Channel (2017-2022)
Table 41. Global OTC Anti-Infective Products Sales Share by Sales Channel (2023-2028)
Table 42. Global OTC Anti-Infective Products Revenue by Sales Channel (2017-2022) & (US$ Million)
Table 43. Global OTC Anti-Infective Products Revenue by Sales Channel (2023-2028) & (US$ Million)
Table 44. Global OTC Anti-Infective Products Revenue Share by Sales Channel (2017-2022)
Table 45. Global OTC Anti-Infective Products Revenue Share by Sales Channel (2023-2028)
Table 46. OTC Anti-Infective Products Price by Sales Channel (2017-2022) & (US$/Unit)
Table 47. Global OTC Anti-Infective Products Price Forecast by Sales Channel (2023-2028) & (US$/Unit)
Table 48. North America OTC Anti-Infective Products Sales by Type (2017-2022) & (M Units)
Table 49. North America OTC Anti-Infective Products Sales by Type (2023-2028) & (M Units)
Table 50. North America OTC Anti-Infective Products Revenue by Type (2017-2022) & (US$ Million)
Table 51. North America OTC Anti-Infective Products Revenue by Type (2023-2028) & (US$ Million)
Table 52. North America OTC Anti-Infective Products Sales by Sales Channel (2017-2022) & (M Units)
Table 53. North America OTC Anti-Infective Products Sales by Sales Channel (2023-2028) & (M Units)
Table 54. North America OTC Anti-Infective Products Revenue by Sales Channel (2017-2022) & (US$ Million)
Table 55. North America OTC Anti-Infective Products Revenue by Sales Channel (2023-2028) & (US$ Million)
Table 56. North America OTC Anti-Infective Products Sales by Country (2017-2022) & (M Units)
Table 57. North America OTC Anti-Infective Products Sales by Country (2023-2028) & (M Units)
Table 58. North America OTC Anti-Infective Products Revenue by Country (2017-2022) & (US$ Million)
Table 59. North America OTC Anti-Infective Products Revenue by Country (2023-2028) & (US$ Million)
Table 60. Europe OTC Anti-Infective Products Sales by Type (2017-2022) & (M Units)
Table 61. Europe OTC Anti-Infective Products Sales by Type (2023-2028) & (M Units)
Table 62. Europe OTC Anti-Infective Products Revenue by Type (2017-2022) & (US$ Million)
Table 63. Europe OTC Anti-Infective Products Revenue by Type (2023-2028) & (US$ Million)
Table 64. Europe OTC Anti-Infective Products Sales by Sales Channel (2017-2022) & (M Units)
Table 65. Europe OTC Anti-Infective Products Sales by Sales Channel (2023-2028) & (M Units)
Table 66. Europe OTC Anti-Infective Products Revenue by Sales Channel (2017-2022) & (US$ Million)
Table 67. Europe OTC Anti-Infective Products Revenue by Sales Channel (2023-2028) & (US$ Million)
Table 68. Europe OTC Anti-Infective Products Sales by Country (2017-2022) & (M Units)
Table 69. Europe OTC Anti-Infective Products Sales by Country (2023-2028) & (M Units)
Table 70. Europe OTC Anti-Infective Products Revenue by Country (2017-2022) & (US$ Million)
Table 71. Europe OTC Anti-Infective Products Revenue by Country (2023-2028) & (US$ Million)
Table 72. Asia Pacific OTC Anti-Infective Products Sales by Type (2017-2022) & (M Units)
Table 73. Asia Pacific OTC Anti-Infective Products Sales by Type (2023-2028) & (M Units)
Table 74. Asia Pacific OTC Anti-Infective Products Revenue by Type (2017-2022) & (US$ Million)
Table 75. Asia Pacific OTC Anti-Infective Products Revenue by Type (2023-2028) & (US$ Million)
Table 76. Asia Pacific OTC Anti-Infective Products Sales by Sales Channel (2017-2022) & (M Units)
Table 77. Asia Pacific OTC Anti-Infective Products Sales by Sales Channel (2023-2028) & (M Units)
Table 78. Asia Pacific OTC Anti-Infective Products Revenue by Sales Channel (2017-2022) & (US$ Million)
Table 79. Asia Pacific OTC Anti-Infective Products Revenue by Sales Channel (2023-2028) & (US$ Million)
Table 80. Asia Pacific OTC Anti-Infective Products Sales by Region (2017-2022) & (M Units)
Table 81. Asia Pacific OTC Anti-Infective Products Sales by Region (2023-2028) & (M Units)
Table 82. Asia Pacific OTC Anti-Infective Products Revenue by Region (2017-2022) & (US$ Million)
Table 83. Asia Pacific OTC Anti-Infective Products Revenue by Region (2023-2028) & (US$ Million)
Table 84. Latin America OTC Anti-Infective Products Sales by Type (2017-2022) & (M Units)
Table 85. Latin America OTC Anti-Infective Products Sales by Type (2023-2028) & (M Units)
Table 86. Latin America OTC Anti-Infective Products Revenue by Type (2017-2022) & (US$ Million)
Table 87. Latin America OTC Anti-Infective Products Revenue by Type (2023-2028) & (US$ Million)
Table 88. Latin America OTC Anti-Infective Products Sales by Sales Channel (2017-2022) & (M Units)
Table 89. Latin America OTC Anti-Infective Products Sales by Sales Channel (2023-2028) & (M Units)
Table 90. Latin America OTC Anti-Infective Products Revenue by Sales Channel (2017-2022) & (US$ Million)
Table 91. Latin America OTC Anti-Infective Products Revenue by Sales Channel (2023-2028) & (US$ Million)
Table 92. Latin America OTC Anti-Infective Products Sales by Country (2017-2022) & (M Units)
Table 93. Latin America OTC Anti-Infective Products Sales by Country (2023-2028) & (M Units)
Table 94. Latin America OTC Anti-Infective Products Revenue by Country (2017-2022) & (US$ Million)
Table 95. Latin America OTC Anti-Infective Products Revenue by Country (2023-2028) & (US$ Million)
Table 96. Middle East and Africa OTC Anti-Infective Products Sales by Type (2017-2022) & (M Units)
Table 97. Middle East and Africa OTC Anti-Infective Products Sales by Type (2023-2028) & (M Units)
Table 98. Middle East and Africa OTC Anti-Infective Products Revenue by Type (2017-2022) & (US$ Million)
Table 99. Middle East and Africa OTC Anti-Infective Products Revenue by Type (2023-2028) & (US$ Million)
Table 100. Middle East and Africa OTC Anti-Infective Products Sales by Sales Channel (2017-2022) & (M Units)
Table 101. Middle East and Africa OTC Anti-Infective Products Sales by Sales Channel (2023-2028) & (M Units)
Table 102. Middle East and Africa OTC Anti-Infective Products Revenue by Sales Channel (2017-2022) & (US$ Million)
Table 103. Middle East and Africa OTC Anti-Infective Products Revenue by Sales Channel (2023-2028) & (US$ Million)
Table 104. Middle East and Africa OTC Anti-Infective Products Sales by Country (2017-2022) & (M Units)
Table 105. Middle East and Africa OTC Anti-Infective Products Sales by Country (2023-2028) & (M Units)
Table 106. Middle East and Africa OTC Anti-Infective Products Revenue by Country (2017-2022) & (US$ Million)
Table 107. Middle East and Africa OTC Anti-Infective Products Revenue by Country (2023-2028) & (US$ Million)
Table 108. Bayer Corporation Information
Table 109. Bayer Description and Major Businesses
Table 110. Bayer OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 111. Bayer OTC Anti-Infective Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Bayer Recent Developments
Table 113. GSK Corporation Information
Table 114. GSK Description and Major Businesses
Table 115. GSK OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 116. GSK OTC Anti-Infective Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. GSK Recent Developments
Table 118. Teva Corporation Information
Table 119. Teva Description and Major Businesses
Table 120. Teva OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 121. Teva OTC Anti-Infective Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Teva Recent Developments
Table 123. Johnson & Johnson Corporation Information
Table 124. Johnson & Johnson Description and Major Businesses
Table 125. Johnson & Johnson OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 126. Johnson & Johnson OTC Anti-Infective Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Johnson & Johnson Recent Developments
Table 128. NOVARTIS Corporation Information
Table 129. NOVARTIS Description and Major Businesses
Table 130. NOVARTIS OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 131. NOVARTIS OTC Anti-Infective Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. NOVARTIS Recent Developments
Table 133. MYLAN Corporation Information
Table 134. MYLAN Description and Major Businesses
Table 135. MYLAN OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 136. MYLAN OTC Anti-Infective Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. MYLAN Recent Developments
Table 138. Sun Pharma Corporation Information
Table 139. Sun Pharma Description and Major Businesses
Table 140. Sun Pharma OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 141. Sun Pharma OTC Anti-Infective Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Sun Pharma Recent Developments
Table 143. CR SANJIU Corporation Information
Table 144. CR SANJIU Description and Major Businesses
Table 145. CR SANJIU OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 146. CR SANJIU OTC Anti-Infective Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. CR SANJIU Recent Developments
Table 148. Cipla Corporation Information
Table 149. Cipla Description and Major Businesses
Table 150. Cipla OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 151. Cipla OTC Anti-Infective Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Cipla Recent Developments
Table 153. Lingrui Corporation Information
Table 154. Lingrui Description and Major Businesses
Table 155. Lingrui OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 156. Lingrui OTC Anti-Infective Products Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Lingrui Recent Developments
Table 158. Key Raw Materials Lists
Table 159. Raw Materials Key Suppliers Lists
Table 160. OTC Anti-Infective Products Distributors List
Table 161. OTC Anti-Infective Products Customers List
Table 162. OTC Anti-Infective Products Market Trends
Table 163. OTC Anti-Infective Products Market Drivers
Table 164. OTC Anti-Infective Products Market Challenges
Table 165. OTC Anti-Infective Products Market Restraints
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. OTC Anti-Infective Products Product Picture
Figure 3. Global OTC Anti-Infective Products Market Share by Type in 2021 & 2028
Figure 3. Antifungal Product Picture
Figure 4. Antibacterial Product Picture
Figure 5. Antiviral Product Picture
Figure 6. Antiseptics Product Picture
Figure 7. Others Product Picture
Figure 8. Global OTC Anti-Infective Products Market Share by Sales Channel in 2021 & 2028
Figure 9. Hospital Pharmacies
Figure 10. Retail Pharmacies
Figure 11. Online Pharmacies
Figure 12. OTC Anti-Infective Products Report Years Considered
Figure 13. Global OTC Anti-Infective Products Sales 2017-2028 (M Units)
Figure 14. Global OTC Anti-Infective Products Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global OTC Anti-Infective Products Revenue 2017-2028 (US$ Million)
Figure 16. Global OTC Anti-Infective Products Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 17. Global OTC Anti-Infective Products Sales Market Share by Region (2017-2022)
Figure 18. Global OTC Anti-Infective Products Sales Market Share by Region (2023-2028)
Figure 19. North America OTC Anti-Infective Products Sales YoY (2017-2028) & (M Units)
Figure 20. North America OTC Anti-Infective Products Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Europe OTC Anti-Infective Products Sales YoY (2017-2028) & (M Units)
Figure 22. Europe OTC Anti-Infective Products Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Asia-Pacific OTC Anti-Infective Products Sales YoY (2017-2028) & (M Units)
Figure 24. Asia-Pacific OTC Anti-Infective Products Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Latin America OTC Anti-Infective Products Sales YoY (2017-2028) & (M Units)
Figure 26. Latin America OTC Anti-Infective Products Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Middle East & Africa OTC Anti-Infective Products Sales YoY (2017-2028) & (M Units)
Figure 28. Middle East & Africa OTC Anti-Infective Products Revenue YoY (2017-2028) & (US$ Million)
Figure 29. The OTC Anti-Infective Products Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 30. The Top 5 and 10 Largest Manufacturers of OTC Anti-Infective Products in the World: Market Share by OTC Anti-Infective Products Revenue in 2021
Figure 31. Global OTC Anti-Infective Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 32. Global OTC Anti-Infective Products Sales Market Share by Type (2017-2028)
Figure 33. Global OTC Anti-Infective Products Revenue Market Share by Type (2017-2028)
Figure 34. Global OTC Anti-Infective Products Sales Market Share by Sales Channel (2017-2028)
Figure 35. Global OTC Anti-Infective Products Revenue Market Share by Sales Channel (2017-2028)
Figure 36. North America OTC Anti-Infective Products Sales Market Share by Type (2017-2028)
Figure 37. North America OTC Anti-Infective Products Revenue Market Share by Type (2017-2028)
Figure 38. North America OTC Anti-Infective Products Sales Market Share by Sales Channel (2017-2028)
Figure 39. North America OTC Anti-Infective Products Revenue Market Share by Sales Channel (2017-2028)
Figure 40. North America OTC Anti-Infective Products Sales Share by Country (2017-2028)
Figure 41. North America OTC Anti-Infective Products Revenue Share by Country (2017-2028)
Figure 42. United States OTC Anti-Infective Products Revenue (2017-2028) & (US$ Million)
Figure 43. Canada OTC Anti-Infective Products Revenue (2017-2028) & (US$ Million)
Figure 44. Europe OTC Anti-Infective Products Sales Market Share by Type (2017-2028)
Figure 45. Europe OTC Anti-Infective Products Revenue Market Share by Type (2017-2028)
Figure 46. Europe OTC Anti-Infective Products Sales Market Share by Sales Channel (2017-2028)
Figure 47. Europe OTC Anti-Infective Products Revenue Market Share by Sales Channe
  • Global Simple Syrup Market Insights and Forecast to 2028
    Published: 18-Jan-2022        Price: US 4900 Onwards        Pages: 93
    Simple Syrup market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Simple Syrup market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Liquid - Syrup - Other Segment by Application - Hospital - Family - Oth......
  • Global Anaesthetic Drugs and Pain Drugs Market Insights and Forecast to 2028
    Published: 18-Jan-2022        Price: US 4900 Onwards        Pages: 89
    Anaesthetic Drugs and Pain Drugs market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Anaesthetic Drugs and Pain Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Anaesthetic Drugs - Pain Drugs Segment by Application......
  • Global D- (+) -Mannose Market Insights and Forecast to 2028
    Published: 18-Jan-2022        Price: US 4900 Onwards        Pages: 95
    D-(+)-Mannose market is segmented by Type and by Application. Players, stakeholders, and other participants in the global D-(+)-Mannose market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Food Grade - Pharmaceutical Grade Segment by Application - Food Additives - Pharmac......
  • Global Small Molecule Active Pharmaceutical Ingredient Market Insights and Forecast to 2028
    Published: 18-Jan-2022        Price: US 4900 Onwards        Pages: 127
    Small Molecule Active Pharmaceutical Ingredient market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Small Molecule Active Pharmaceutical Ingredient market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Standard API - High Potency API ......
  • Global Wound-cleaning Potion Market Insights and Forecast to 2028
    Published: 18-Jan-2022        Price: US 4900 Onwards        Pages: 106
    Wound-cleaning Potion market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Wound-cleaning Potion market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Normal Saline - Hydrogen Peroxide - Metronidazole - Iodophor Disinfectant -......
  • Global Ocular Drug Delivery Market Insights and Forecast to 2028
    Published: 18-Jan-2022        Price: US 4900 Onwards        Pages: 110
    Ocular Drug Delivery market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Ocular Drug Delivery market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Ocular Insert - Iontophoresis - Intraocular Implants - In Situ Gel & Punctal Plugs......
  • Global Transdermal Skin Patch Market Insights and Forecast to 2028
    Published: 18-Jan-2022        Price: US 4900 Onwards        Pages: 108
    Transdermal Skin Patch market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Transdermal Skin Patch market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Fentanyl Transdermal Skin Patch - Nicotine Transdermal Skin Patch - Clonidine Transderm......
  • Global Chronic Kidney Disease Drugs Market Insights and Forecast to 2028
    Published: 18-Jan-2022        Price: US 4900 Onwards        Pages: 113
    Chronic Kidney Disease Drugs market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Chronic Kidney Disease Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - ACE Inhibitors - Calcium Channel Blockers - Beta Blockers - Others......
  • Global Nanostructured Drug Market Insights and Forecast to 2028
    Published: 18-Jan-2022        Price: US 4900 Onwards        Pages: 128
    Nanostructured Drug market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Nanostructured Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Liposomes - Polymeric Micelles - Solid lipid Nanoparticles - Microemulsion and Nanoemu......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs